Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example

Keyphrases

• Neoantigen 100%
• Type 1 Diabetes Mellitus (T1DM) 100%
• Mass Spectrometry 100%
• Autoimmune Disease 100%
• Type I Diabetes 100%
• Major Histocompatibility Complex 66%
• Post-translational Modification 33%
• Major Histocompatibility Complex Molecules 33%
• Autoantibodies 33%
• Self-antigens 33%
• Valuable Insight 33%
• Autoreactive T Cells 33%
• Binding Motif 33%
• Plethora 33%
• Peptide Antigen 33%
• Autoreactivity 33%
• Disease Identification 33%
• Interface Residues 33%
• Immunopeptidomics 33%

Immunology and Microbiology

• Major Histocompatibility Complex 100%
• Autoimmune Disease 100%
• Neoantigen 100%
• T Cell 33%
• T Cell Receptor 33%
• Autoantibodies 33%
• Peptides 33%
• Post-Translational Modification 33%
• Immunopeptidomics 33%